Sales Milestone Payments Sample Clauses
The Sales Milestone Payments clause establishes that certain payments are triggered when specific sales targets or milestones are achieved. In practice, this means that the party receiving payment will only be compensated upon reaching predefined sales figures, such as a set number of units sold or a particular revenue threshold. This clause ensures that payments are directly tied to performance, incentivizing the achievement of sales goals and aligning the interests of both parties.
POPULAR SAMPLE Copied 10 times
Sales Milestone Payments. Artiva shall make the following one-time, non-refundable and non-creditable sales milestone payments to GCLC when the aggregate annual Net Sales of Products in the Territory first reach the thresholds specified below. Artiva shall notify GCLC promptly of the achievement of each such sales threshold. Each sales milestone payment shall be made by Artiva within [***] days after the end of the calendar quarter in which such sales threshold is achieved. To the extent more than one sales threshold is reached in any given calendar year, then the applicable milestone payment for each such achievement shall be due and owing with respect to such calendar year. For clarification, the total milestone payments payable hereunder if all milestone events are achieved is [***].
Sales Milestone Payments. (a) Pharming will make each of the following one time Milestone Payments for sales (the “Sales Milestone Payments”) when worldwide, aggregate Net Sales of Licensed Products by or on behalf of Pharming, its Affiliates or Sublicensees in a given Calendar Year first meets the corresponding Net Sales thresholds set forth in the chart below (such thresholds, the “Sales Milestones”): First time annual Net Sales of Licensed Products exceed [***] [***] First time annual Net Sales of Licensed Products exceed [***] [***] First time annual Net Sales of Licensed Products exceed [***] [***]
(b) Each Sales Milestone Payment in the table above will be paid only once, and will be deemed irrevocably earned as of the first achievement of the corresponding Sales Milestone. If more than one unmet Sales Milestone is achieved in a given Calendar Year, a Sales Milestone Payment will be made with respect to the highest unmet Sales Milestone achieved in such Calendar Year in accordance with the following sentence, and a Sales Milestone Payment will be made with respect to each lesser included Sales Milestone within [***] days after the anniversary of such payment, one Sales Milestone Payment per Calendar Year, until all earned Sales Milestone Payments have been made. Pharming will provide Novartis with written notice of the achievement of each Sales Milestone within [***] days after such Sales Milestone is achieved by or on behalf of Pharming, its Affiliates or their respective Sublicensee(s), and the corresponding Sales Milestone Payment will be paid by Pharming within [***] days after the Calendar Year in which the relevant Sales Milestone is achieved.
Sales Milestone Payments. With respect to each of the First Antibody and the Subsequent Antibody, Pieris shall pay the following sales milestone payments to Enumeral by the later of (i) [***] days of the occurrence of [***] and [***] Product to achieve each of the following events and (ii) [***] days of the occurrence of the following events for any corresponding milestone payment with respect to any payment from Sublicensee to Pieris: Net sales threshold [***] Product [***] Product 1st year with Net Sales [***] [***] [***] 1st year with Net Sales [***] [***] [***] 1st year with Net Sales [***] [***] [***] Total [***] [***] Grand Total $67,500,000 (sixty seven million five hundred thousand dollars) For avoidance of any doubt, in no event shall milestone payments paid by Pieris under this Section 4.4 exceed $67,500,000 (sixty-seven million five hundred thousand dollars) for the First Antibody and $67,500,000 (sixty-seven million five hundred thousand dollars) for the Subsequent Antibody. Net Sales shall be calculated on a worldwide basis.
Sales Milestone Payments. 6.5.1 Subject to Section 6.5.2, in consideration for Nucryst agreeing to grant S&N a license for the use in the manner specified in this Agreement of the Nucryst Technology and agreeing to enter into this Agreement, and in addition to the royalties and other payments provided for elsewhere in this Article 6, S&N shall pay to Nucryst the following sales milestone payments in respect of Sales of Products made by S&N (and its Affiliates) from the Original Effective Date within fifteen (15) days of achieving each such sales milestone:
6.5.1.1 five million dollars ($5,000,000) upon Net Sales in any four (4) consecutive calendar quarters for all Products in the Territory exceeding for the first time [***] (paid);
6.5.1.2 five million dollars ($5,000,000) upon Net Sales in any four (4) consecutive calendar quarters for all Products in the Territory exceeding for the first time [***] (paid);
6.5.1.3 five million dollars ($5,000,000) upon Net Sales in any four (4) consecutive calendar quarters for all Products in the Territory exceeding for the first time [***] (paid);
6.5.1.4 five million dollars ($5,000,000) upon Net Sales in any four (4) consecutive calendar quarters for all Products in the Territory exceeding for the first time [***] (S&N and Nucryst agree that this milestone has been met and is payable by S&N to Nucryst on the Effective Date);
6.5.1.5 [***] upon Net Sales in any four (4) consecutive calendar quarters for all Products exceeding for the first time [***];
6.5.1.6 [***] upon Net Sales in any four (4) consecutive calendar quarters for all Products exceeding for the first time [***]; and
6.5.1.7 [***] upon Net Sales in any four (4) consecutive calendar quarters for all Products exceeding for the first time [***]. For clarification, each of S&N’s sales milestone payments identified in this Section 6.5 shall be made only once for the stated sales milestone triggering event. However, more than one (1) sales milestone may be achieved in a particular four consecutive quarter time period, in which case (if not previously paid) each such sales milestone payment shall be made by S&N to Nucryst. All sales milestone payments made by S&N under this Section 6.5 are non-refundable to S&N.
6.5.2 The sales milestone payments provided for in Section 6.5.1 shall be apportioned between Canada, the United States, and the rest of the world based on the ratio that Net Sales in Canada, the United States, and the rest of the world, as applicable, for such Products bear to...
Sales Milestone Payments. With respect to each Designated Target:
(a) A milestone payment of [***] Dollars ($[***]) shall be payable by BMS to Schrödinger when the total Net Sales within a given Calendar Year of all Licensed Collaboration Product(s) for such Designated Target in the Territory by BMS, its Affiliates and Sublicensees first equals or exceeds [***] Dollars ($[***]).
(b) A milestone payment of [***] Dollars ($[***]) shall be payable by BMS to Schrödinger when the total Net Sales within a given Calendar Year of all Licensed Collaboration Product(s) for such Designated Target in the Territory by BMS, its Affiliates and Sublicensees first equals or exceeds [***] Dollars ($[***]).
(c) A milestone payment of [***] Dollars ($[***]) shall be payable by BMS to Schrödinger when the total Net Sales within a given Calendar Year of all Licensed Collaboration Product(s) for such Designated Target in the Territory by BMS, its Affiliates and Sublicensees first equals or exceeds [***] Dollars ($[***]). The sales-based milestones set forth in clauses (a) through (c) above shall be payable only once for each Designated Target, and in any event shall not exceed two hundred twenty-five million Dollars ($225,000,000) in the aggregate for such Designated Target. Each sales-based milestone that becomes payable under this Section 8.3 shall be due within [***] following the end of the Calendar Year in which the Licensed Collaboration Product(s) for such Designated Target first reaches the applicable Net Sales threshold. More than one of the sales-based milestone payments in this Section 8.3 may be payable for a given Designated Target based on the same Calendar Year Net Sales of the Licensed Collaboration Product(s) for such Designated Target. For example, if more than one sales-based milestone set forth in clauses (a) through (c) above for a given Designated Target is achieved in the same Calendar Year, then each corresponding sales-based milestone payment for such sales-based milestone events for such Designated Target shall be payable. Such sales-based milestone payments will be noncreditable, nonrefundable and not subject to set off.
Sales Milestone Payments. Subject to Section 10.8.4, on a Licensed Target-by-Licensed Target basis, Novartis will make one-time payments of each of the sales milestone payments indicated below (each, a “Sales Milestone Payment” and together with the Developmental Milestone Payments, the “Milestone Payments”) to Surface when aggregate Annual Net Sales of all Licensed Products for such Licensed Target in the Territory in a given Calendar Year first reach the dollar values indicated on each table below for the applicable T1 Licensed Products, Global Licensed Products or Regional Licensed Products (each, a “Sales Milestone Event”). Notwithstanding any other provision of this Agreement, each series of Sales Milestone Payments will be payable only once with respect to the specified Licensed Target, notwithstanding the number of Licensed Products (or the number of times a Licensed Product) may achieve the applicable Sales Milestone Event.
Sales Milestone Payments. As additional consideration for the rights granted to Indivior herein, Indivior shall pay to Addex a one-time milestone payment upon first achieving each of the Annual Net Sales thresholds set forth below (“Sales Milestone Payments”). For the avoidance of doubt, each Milestone Payment shall be payable one-time only upon the first occurrence of the event triggering the respective milestone provided below. First time Annual Net Sales exceed [***] [***] First time Annual Net Sales exceed [***] [***] First time Annual Net Sales exceed [***] [***] First time Annual Net Sales exceed [***] [***] First time Annual Net Sales exceed [***] [***] First time Annual Net Sales exceed [***] [***] First time Annual Net Sales exceed [***] [***] First time Annual Net Sales exceed [***] [***] Total [***]
Sales Milestone Payments. 14 7.4 Royalties .................................................. 14 7.5 Manner and Place of Payment ................................ 15 7.6 Records and Audit of Sales and Expenses .................... 15 ARTICLE 8. CONFIDENTIALITY ............................................ 16
Sales Milestone Payments. Sublicensee will pay to Sublicensor the following non-refundable, one-time milestone payments as follows:
(a) Within sixty (60) days following attainment of annual Net Sales in Japan equal to *****.
(b) Within sixty (60) days following attainment of annual Net Sales in Japan equal to *****.
(c) Within sixty (60) days following attainment of annual Net Sales in Japan equal to *****. For purposes of this Section 4.3, annual Net Sales shall be calculated on a calendar year basis. Nothing herein shall preclude multiple milestone payments from being paid in a given 12-month period if multiple milestones have been reached.
Sales Milestone Payments. (a) U.S. Events. AstraZeneca shall make each of the sales milestone payments indicated below to FibroGen when aggregate Annual Net Sales of all Products across all indications in the U.S. (other than sales by FibroGen in indications independently developed by FibroGen pursuant to Section 3.3(b) for which AstraZeneca does not opt in) first reach the Dollar values indicated below. Each milestone in this Section 8.5(a) shall be paid only once.